Hostname: page-component-848d4c4894-8bljj Total loading time: 0 Render date: 2024-07-03T14:11:18.398Z Has data issue: false hasContentIssue false

Favourable outcome of a severe bradyarrhythmia in a neonate: a case report

Published online by Cambridge University Press:  08 August 2022

Dwayne Mascarenhas
Affiliation:
Department of Neonatology, Seth GS Medical College & KEM Hospital, Mumbai, India
Medha Goyal*
Affiliation:
Department of Neonatology, Seth GS Medical College & KEM Hospital, Mumbai, India
Ruchi Nanavati
Affiliation:
Department of Neonatology, Seth GS Medical College & KEM Hospital, Mumbai, India
*
Address for correspondence: Dr. Medha Goyal, DM, Department of Neonatology, 10th Floor, MSB, KEM Hospital, Parel, Mumbai 400 012, India. Tel: +91 9911961790. E-mail: medha_kv@yahoo.com

Abstract

We report the case of a term neonate with severe fetal bradycardia with an unusually benign clinical course with follow-up till infancy.

Type
Brief Report
Copyright
© The Author(s), 2022. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Michaëlsson, M, Engle, MA. Congenital complete heart block: an international study of the natural history. Cardiovasc Clin. 1972; 4: 85101.Google Scholar
Buyon, JP, Hiebert, R, Copel, J, et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol. 1998; 31: 16581666.CrossRefGoogle ScholarPubMed
Brito-Zerón, P, Izmirly, PM, Ramos-Casals, M, Buyon, JP, Khamashta, MA. The clinical spectrum of autoimmune congenital heart block. Nat Rev Rheumatol. 2015; 11: 301312.CrossRefGoogle ScholarPubMed
Ho, SY, Esscher, E, Anderson, RH, Michaëlsson, M. Anatomy of congenital complete heart block and relation to maternal anti-Ro antibodies. Am J Cardiol. 1986; 58: 291294.CrossRefGoogle ScholarPubMed
Brucato, A. Prevention of congenital heart block in children of SSA-positive mothers. Rheumatology (Oxford) 2008; 47 Suppl 3: iii357.CrossRefGoogle ScholarPubMed
Friedman, DM, Llanos, C, Izmirly, PM, et al. Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: results of a multicenter, prospective, open-label clinical trial. Arthritis Rheum. 2010; 62: 11381146.CrossRefGoogle Scholar
Buyon, JP, Clancy, RM, Friedman, DM. Autoimmune associated congenital heart block: integration of clinical and research clues in the management of the maternal/foetal dyad at risk. J Intern Med. 2009; 265: 653662.CrossRefGoogle ScholarPubMed
Shokrzadeh, A, Maltret, A, Morel, N, et al. Longitudinal analysis of fetal ventricular rate for risk stratification in immune congenital heart block. Fetal Diagn Ther. 2021; 48: 18.CrossRefGoogle ScholarPubMed
Reid, JM, Coleman, EN, Doig, W. Complete congenital heart block. Report of 35 cases. Br Heart J. 1982; 48: 236239.CrossRefGoogle ScholarPubMed
Tunaoglu, FS, Yildirim, A, Vurali, D. Isolated congenital heart block. Tex Heart Inst J. 2010; 37: 579583.Google ScholarPubMed
Jaeggi, ET, Hamilton, RM, Silverman, ED, Zamora, SA, Hornberger, LK. Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block. A single institution’s experience of 30 years. J Am Coll Cardiol. 2002; 39: 130137.CrossRefGoogle ScholarPubMed
Glikson, M, Nielsen, JC, Kronborg, MB, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2021; 42: 34273520.CrossRefGoogle ScholarPubMed